In this exciting episode of SciBud, host Rowan takes us on a journey into the intricate world of virology and structural biology, unveiling groundbreaking research on herpesvirus replication. We'll explore how antiviral compounds pritelivir and amenamevir inhibit the replication of human herpes simplex virus type 1 (HSV-1)—a common virus linked to cold sores and more serious health concerns. Using cutting-edge cryo-electron microscopy, researchers have captured the helicase-primase complex, a key molecular player in viral DNA replication, in stunning detail. Discover how these inhibitors interlock within the complex, thwarting the virus’s life cycle, and why their potential to outsmart viral resistance makes them promising candidates for future antiviral therapies. Join us as we delve into the structural insights that could revolutionize our approach to fighting HSV-1 and spark new hope for millions worldwide! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/248